NM_021098.3:c.2229G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):​c.2229G>A​(p.Thr743Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000852 in 1,611,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00088 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.59

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 16-1204236-G-A is Benign according to our data. Variant chr16-1204236-G-A is described in ClinVar as [Benign]. Clinvar id is 529639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.6 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000584 (89/152322) while in subpopulation AMR AF = 0.00105 (16/15308). AF 95% confidence interval is 0.000742. There are 0 homozygotes in GnomAd4. There are 49 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 89 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.2190G>A p.Thr730Thr synonymous_variant Exon 10 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.2190G>A p.Thr730Thr synonymous_variant Exon 10 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2229G>A p.Thr743Thr synonymous_variant Exon 10 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*142G>A non_coding_transcript_exon_variant Exon 10 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*1676G>A non_coding_transcript_exon_variant Exon 9 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2229G>A non_coding_transcript_exon_variant Exon 10 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*142G>A 3_prime_UTR_variant Exon 10 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*1676G>A 3_prime_UTR_variant Exon 9 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000585
AC:
89
AN:
152204
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000533
AC:
128
AN:
240174
AF XY:
0.000539
show subpopulations
Gnomad AFR exome
AF:
0.000345
Gnomad AMR exome
AF:
0.000205
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00106
Gnomad OTH exome
AF:
0.000340
GnomAD4 exome
AF:
0.000879
AC:
1283
AN:
1458784
Hom.:
0
Cov.:
32
AF XY:
0.000852
AC XY:
618
AN XY:
725632
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33434
American (AMR)
AF:
0.000180
AC:
8
AN:
44548
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26074
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86018
European-Finnish (FIN)
AF:
0.0000386
AC:
2
AN:
51878
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.00110
AC:
1223
AN:
1111180
Other (OTH)
AF:
0.000664
AC:
40
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
82
165
247
330
412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000584
AC:
89
AN:
152322
Hom.:
0
Cov.:
33
AF XY:
0.000658
AC XY:
49
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41566
American (AMR)
AF:
0.00105
AC:
16
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000926
AC:
63
AN:
68012
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00109
Hom.:
0
Bravo
AF:
0.000684
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
4.3
DANN
Benign
0.82
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111986908; hg19: chr16-1254236; API